Protara Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $332 | $0 |
Gross Profit | -98 | -83 | 166 | -84 |
EBITDA | -16,586 | -14,124 | -14,230 | -12,246 |
EBIT | -14,207 | -14,312 | -12,330 | |
Net Income | -14,960 | -11,914 | -12,769 | -11,219 |
Net Change In Cash | 0 | 0 | 332 | 0 |
Free Cash Flow | -12,272 | -14,757 | -9,308 | -8,442 |
Cash | 31,496 | 91,461 | 162,798 | 51,757 |
Basic Shares | 42,270 | 40,707 | 26,432 | 22,329 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -332 | -341 | -247 | -1,167 |
EBITDA | -49,154 | -43,272 | -64,568 | -46,085 |
EBIT | -40,425 | -43,613 | -64,815 | -47,252 |
Net Income | -44,596 | -40,420 | -65,952 | -47,135 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -35,871 | -37,602 | -26,577 | -35,098 |
Cash | 162,798 | 39,586 | 24,127 | 35,724 |
Basic Shares | 20,592 | 11,331 | 11,259 | 11,232 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.35 |
2025-03-31 | -$0.29 |
2024-12-31 | -$0.43 |
